CRYSTALLINE FORM OF 3-(1-HYDROXY-1-METHYL-ETHYL)-1-(4-METHOXY-PHENYL)-6-[4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-1,4,5,6-TETRAHYDRO-PYRAZOLO[3,4-C]PYRIDIN-7-ONE AS A FACTOR XA INHIBITOR

摘要

The instant invention provides crystalline forms of 3-(1-hydroxy-1-methyl-ethyl)-1-(4-methoxy-phenyl)-6-[4-(2-oxo-2H-pyridin-1-yl)-phenyl]-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-one and its solvates thereof; processes for the production of such crystalline forms; pharmaceutical compositions comprising such crystalline forms; and methods of treating thromboembolic disorders with such crystalline forms or such pharmaceutical compositions.